Suppr超能文献

多药耐药相关蛋白 2 缺陷(TR)大鼠中内源性粪卟啉原 I 和 III 发生改变。

Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR) Rats.

机构信息

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Pharmacology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

J Pharm Sci. 2021 Jan;110(1):404-411. doi: 10.1016/j.xphs.2020.10.017. Epub 2020 Oct 13.

Abstract

Recent studies have focused on coproporphyrin (CP)-I and CP-III (CPs) as endogenous biomarkers for organic anion transporting polypeptides (OATPs). Previous data showed that CPs are also substrates of multidrug resistance-associated protein (MRP/Mrp) 2 and 3. This study was designed to examine the impact of loss of Mrp2 function on the routes of excretion of endogenous CPs in wild-type (WT) Wistar compared to Mrp2-deficient TR rats. To exclude possible confounding effects of rat Oatps, the transport of CPs was investigated in Oatp-overexpressing HeLa cells. Results indicated that CPs are substrates of rodent Oatp1b2, and that CP-III is a substrate of Oatp2b1. Quantitative targeted absolute proteomic (QTAP) analysis revealed no differences in Oatps, but an expected significant increase in Mrp3 protein levels in TR compared to WT rat livers. CP-I and CP-III concentrations measured by LC-MS/MS were elevated in TR compared to WT rat liver, while CP-I and CP-III estimated biliary clearance was decreased 75- and 840-fold in TR compared to WT rats, respectively. CP-III concentrations were decreased 14-fold in the feces of TR compared to WT rats, but differences in CP-I were not significant. In summary, the disposition of CPs was markedly altered by loss of Mrp2 and increased Mrp3 function as measured in TR rats.

摘要

最近的研究集中在粪卟啉(CP)-I 和 CP-III(CPs)作为有机阴离子转运多肽(OATPs)的内源性生物标志物。先前的数据表明,CPs 也是多药耐药相关蛋白(MRP/Mrp)2 和 3 的底物。本研究旨在研究 Mrp2 功能丧失对野生型(WT)Wistar 大鼠与 Mrp2 缺陷型 TR 大鼠内源性 CP 排泄途径的影响。为了排除大鼠 Oatps 可能的混杂影响,在过表达 Oatp 的 HeLa 细胞中研究了 CP 的转运。结果表明,CPs 是啮齿动物 Oatp1b2 的底物,CP-III 是 Oatp2b1 的底物。定量靶向绝对蛋白质组学(QTAP)分析显示 Oatps 没有差异,但 TR 大鼠肝脏中 Mrp3 蛋白水平预计会显著增加。与 WT 大鼠肝脏相比,TR 大鼠肝脏中 CP-I 和 CP-III 的浓度通过 LC-MS/MS 测量升高,而 CP-I 和 CP-III 的估计胆汁清除率分别降低了 75 倍和 840 倍。与 WT 大鼠相比,TR 大鼠粪便中的 CP-III 浓度降低了 14 倍,但 CP-I 没有显著差异。总之,CPs 的处置在 TR 大鼠中由于 Mrp2 的丧失和 Mrp3 功能的增加而明显改变。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验